SCHEMBL20508364

SCHEMBL20508364

CN(C)c1ccccc1C1N(C)c2ccccc2N1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDGFRB P09619 1/20 0.53
▸ LMNA P02545 1/20 0.46
▸ KDM4E B2RXH2 3/20 0.41
▸ GAA P10253 3/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ GPR3 P46089 1/20 0.39
▸ HDAC4 P56524 1/20 0.39
▸ HDAC7 Q8WUI4 1/20 0.39
▸ HDAC5 Q9UQL6 1/20 0.39
▸ HTT P42858 1/20 0.37
▸ MAPT P10636 2/20 0.34
▸ TP53 P04637 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ ADRA2A P08913 1/20 0.33
▸ ADRA2B P18089 1/20 0.33
▸ ADRA2C P18825 1/20 0.33
▸ SLC6A2 P23975 1/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ HTR2C P28335 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21970632 0.89 PDGFRB (0.42) PDGFRBLMNAKDM4EGAAALDH1A1
SCHEMBL21972252 0.88 PDGFRB (0.42) PDGFRBLMNAKDM4EGAAALDH1A1
SCHEMBL21971402 0.86 PDGFRB (0.47) PDGFRBLMNAKDM4EGAAALDH1A1
SCHEMBL21970991 0.85 PDGFRB (0.51) PDGFRBLMNAKDM4EGAAALDH1A1
SCHEMBL21971007 0.82 LMNA (0.49) PDGFRBLMNAKDM4EGAAALDH1A1
SCHEMBL21971003 0.81 PDGFRB (0.58) PDGFRBLMNAKDM4EGAAALDH1A1
SCHEMBL21971400 0.81 PDGFRB (0.58) PDGFRBLMNAKDM4EGAAALDH1A1
SCHEMBL21971004 0.81 PDGFRB (0.53) PDGFRBLMNAKDM4EGAAALDH1A1
SCHEMBL21971408 0.75 PDGFRB (0.47) PDGFRBLMNAKDM4EGAAALDH1A1
SCHEMBL21972253 0.75 PDGFRB (0.40) PDGFRBLMNAKDM4EGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11046655-B2 Compound and method for producing same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-06-29 — — US disclosed
US-10763438-B2 n-Doped electrically conductive polymeric material NATIONAL UNIVERSITY OF SINGAPORE (SG) 2020-09-01 — — US disclosed
US-20200140394-A1 NOVEL COMPOUND AND METHOD FOR PRODUCING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2020-05-07 — — US disclosed
US-20180277764-A1 A N-DOPED ELECTRICALLY CONDUCTIVE POLYMERIC MATERIAL NATIONAL UNIVERSITY OF SINGAPORE (SG) 2018-09-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200140394-A1 NOVEL COMPOUND AND METHOD FOR PRODUCING SAME CBR3, NR2E3, NR5A2 PDGFRB 2517/4885LMNA 4733/4885KDM4E 4526/4885
US-11046655-B2 Compound and method for producing same CBR3, NR5A1, NR2E3 PDGFRB 2499/4885LMNA 4570/4885KDM4E 4760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback